See also this year's filing and all EDGAR filings for this company.
PDF Report 0001644963_2018_Avenue_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001644963', 'EntityCommonStockSharesOutstanding': 10662398, 'Assets': 4525000, 'AssetsCurrent': 0, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 5156000, 'LiabilitiesAndStockholdersEquity': 4525000, 'LiabilitiesCurrent': 5156000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -21548000, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 4525000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': -631000, 'remainder_NetIncome': -21548000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
Graph
Absolute values for 0001644963, Avenue Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 22,170,000 |
| 4 | LiabilitiesCurrent | 2,790,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 925,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -11,333,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 22,170,000 |
| 1 | Liabilities | 2,790,000 |
| 2 | Expenses | 925,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 19,380,000 |
| 5 | NetIncome | -12,258,000 |
| 6 | ComprehensiveNetIncome | -12,258,000 |
| 7 | BaseVar | 18,609,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.40 |
| 9 | EconomicCapitalRatio | 3.29 |
Edgar->Model Mapping
Feature Distribution
